Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab.

Journal:

Hepatology

Published:

2025-07-01

DOI:

10.1097/hep.0000000000001444

Affiliations:

9

Authors:

25

Go to article

Institutions	Authors	Share
The Catholic University of Korea (CUK), South Korea	11.500000 11.500000	0.46
Seoul St. Mary's Hospital, South Korea	3.000000	0.12
Yonsei University, South Korea	2.000000	0.08
Incheon St. Mary's Hospital, South Korea	1.500000	0.06
Bucheon St. Mary's Hospital, South Korea	1.500000	0.06
St. Vincent's Hospital, South Korea	1.500000	0.06
Uijeongbu St. Mary's Hospital, South Korea	1.500000	0.06
Eunpyeong St. Mary's Hospital, South Korea	1.500000	0.06
Daejeon St. Mary's Hospital, South Korea	1.000000	0.04

Interested in Oncology and Carcinogenesis?